Year Established :
1998
Total Assets(USD) :
5,000,000 to 5,999,999
Total Number of Staff :
60 to 69
Main Competitive Advantages :
Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Quality Service
Other Competitive Advantages :
Specialized in manufacturing nucleotides.
Patents and Copyrights :
Calcium dibutyryl adenosine cyclophosphate
Business Type :
Manufacturer
Annual Turnover(USD) :
15,000,000 to 19,999,999
Main Sales Markets :
North America,Central/South America,Eastern Europe,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Bio Products
Product Range :
Nucleotides